G21.19
BillableOther drug induced secondary parkinsonism
Other drug induced secondary parkinsonism
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Other medication-induced parkinsonism
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Excludes 2
Conditions not included here, but the patient may have both
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Use Additional Code
Additional codes that should follow this code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Also Known As / Clinical Terms
SNOMED CT
- Parkinsonism caused by drug4223005
- Manganese-induced parkinsonism230294009
- Methanol-induced Parkinsonism870288002
- Parkinsonism caused by methanol870288002
- Dopamine receptor antagonist-induced parkinsonism1260379008
- Parkinsonism caused by dopamine blocking agent1260379008
- Parkinsonism caused by dopamine receptor antagonist1260379008
- Dopamine depleting agent-induced parkinsonism1260381005
- Parkinsonism caused by dopamine depleting agent1260381005
Frequently Asked Questions
What is the ICD-10 code for other drug induced secondary parkinsonism?
The ICD-10-CM code for other drug induced secondary parkinsonism is G21.19. The full clinical description is "Other drug induced secondary parkinsonism". G21.19 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code G21.19 mean?
ICD-10-CM code G21.19 represents "Other drug induced secondary parkinsonism". It is classified under Chapter 6: Diseases of the Nervous System and is a billable/specific code that can be used on a claim.
Is G21.19 a billable code?
Yes, G21.19 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is G21.19 in?
G21.19 is in Chapter 6: Diseases of the Nervous System (codes G00-G99).
What codes cannot be used with G21.19?
G21.19 has Excludes1 notes indicating codes that cannot be used together with it, including: Huntington's disease (G10); neurocognitive disorder with Lewy bodies (G31.83); Shy-Drager syndrome (G90.3); and 1 more.
Are additional codes required with G21.19?
Yes, when using G21.19 you should also code: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5).
What SNOMED CT codes does G21.19 map to?
G21.19 maps to 5 SNOMED CT concepts: 1260381005, 1260379008, 230294009, 870288002, 4223005. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for G21.19?
G21.19 is linked to 2 UMLS Concept Unique Identifiers: C0477356, C4237315. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.